|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities | |||||
| Stock-based compensation | |||||
| Amortization of operating lease right-of-use assets | |||||
| Depreciation | |||||
| In-process research and development | |||||
| Loss on disposal of property and equipment | |||||
| Amortization (accretion) of premiums (discounts) on securities, net | |||||
| Changes in operating assets and liabilities: | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable | |||||
| Accrued expenses and other liabilities | |||||
| Operating lease liabilities | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities | |||||
| Proceeds from maturities of securities | |||||
| Purchases of securities | |||||
| Purchases of property and equipment | |||||
| Cash paid in connection with asset acquisition | |||||
| Net cash provided by investing activities | |||||
| Cash flows from financing activities | |||||
| Proceeds from exercise of stock options | |||||
| Proceeds from issuance of common stock under employee stock purchase plan | |||||
| Net cash provided by financing activities | |||||
| Net increase (decrease) in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash at beginning of period | |||||
| Cash, cash equivalents and restricted cash at end of period | |||||
| Supplementary cash flow information on non-cash activities: | |||||
| Acquisitions of property and equipment included in accounts payable | |||||
| Right-of-use assets obtained in exchange for operating lease liability | |||||
| Remeasurement of lease liabilities and right-of-use assets | |||||
Loading...